Retina/Vitreous News

A review of guidelines for neovascular age-related macular degeneration shows a high level of agreement on the use of optical coherence tomography and visual acuity in diagnosis and monitoring.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Baruch D. Kuppermann, MD, PhD, comments on the decision of the European Medicines Agency to reject the appeal for the approval of pegcetacoplan.

Ellipsoid zone integrity may be an important biomarker in predicting the progression of geographic atrophy in eyes with dry age-related macular degeneration.

BARCELONA, Spain — In this Healio Video Perspective from the ESCRS meeting, Federico Badalà, MD, shares his experience with the EyeMax Mono IOL in patients with insignificant cataract and dry age-related macular degeneration.

The FDA granted fast track designation to brepocitinib for the treatment of nonanterior noninfectious uveitis, according to a press release from Priovant Therapeutics.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Anat Loewenstein, MD, MHA, Euretina president, gives an overview of the variety of topics discussed here and the initiatives launched by the society.

BARCELONA, Spain — In this Healio Video Perspective, Jean-François Korobelnik, MD, PhD, discusses the decision of the European Medicines Agency to reject marketing authorization of pegcetacoplan in Europe.

The Committee for Medicinal Products for Human Use of the European Medicines Agency confirmed its negative opinion on the marketing authorization application for intravitreal pegcetacoplan for geographic atrophy.

Healio spoke with Aleksandra Rachitskaya, MD, a vitreoretinal surgeon and associate professor of ophthalmology at Cleveland Clinic Cole Eye Institute, about mental health conditions in patients with age-related macular degeneration.

Oral gildeuretinol acetate did not meet the primary endpoint of geographic atrophy lesion growth rate in a phase 3 study, according to a press release from Alkeus Pharmaceuticals.